Melatonin: Characteristics, concerns, and prospects

被引:210
作者
Arendt, J [1 ]
机构
[1] Univ Surrey, Sch Biomed & Mol Sci, Ctr Chronobiol, Guildford GU2 7XH, Surrey, England
关键词
melatonin; light; rhythms; human;
D O I
10.1177/0748730405277492
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Melatonin is of great importance to the investigation of human biological rhythms. Its rhythm in plasma or saliva provides the best available measure of the timing of the internal circadian clock. Its major metabolite 6-sulphatoxymelatonin is robust and easily measured in urine. It thus enables long-term monitoring of human rhythms in real-life situations where rhythms may be disturbed, and in clinical situations where invasive procedures are difficult. Melatonin is not only a "hand of the clock"; endogenous melatonin acts to reinforce the functioning of the human circadian system, probably in many ways. Most is known about its relationship to sleep and the decline in core body temperature and alertness at night. Current perspectives also include a possible influence on major disease risk, arising from circadian rhythm disruption. Melatonin clearly has the ability to induce sleepiness and lower core body temperature during "biological day" and to change the timing of human rhythms when treatment is appropriately timed. It can entrain free-running rhythms and maintain entrainment in most blind and some sighted people. Used therapeutically it has proved a successful treatment for circadian rhythm disorder, particularly the non-24-h sleep wake disorder of the blind. Numerous other clinical applications are under investigation. There are, however, areas of controversy, large gaps in knowledge, and insufficient standardization of experimental conditions and analysis for general conclusions to be drawn with regard to most situations. The future holds much promise for melatonin as a therapeutic treatment. Most interesting, however, will be the dissection of its effects on human genes.
引用
收藏
页码:291 / 303
页数:13
相关论文
共 118 条
  • [31] Effects of chronic jet lag on tumor progression in mice
    Filipski, E
    Delaunay, F
    King, VM
    Wu, MW
    Claustrat, B
    Gréchez-Cassiau, A
    Guettier, C
    Hastings, MH
    Francis, L
    [J]. CANCER RESEARCH, 2004, 64 (21) : 7879 - 7885
  • [32] The circadian clock: Pacemaker and tumour suppressor
    Fu, LN
    Lee, CC
    [J]. NATURE REVIEWS CANCER, 2003, 3 (05) : 350 - 361
  • [33] Local polynomial regression modeling of human plasma melatonin levels
    Gamst, A
    Wolfson, T
    Parry, B
    [J]. JOURNAL OF BIOLOGICAL RHYTHMS, 2004, 19 (02) : 164 - 174
  • [34] Estimation of frequently sampled nocturnal melatonin production in humans by deconvolution analysis: Evidence for episodic or ultradian secretion
    Geoffriau, M
    Claustrat, B
    Veldhuis, J
    [J]. JOURNAL OF PINEAL RESEARCH, 1999, 27 (03) : 139 - 144
  • [35] Adaptation of the circadian rhythm of 6-sulphatoxymelatonin to a shift schedule of seven nights followed by seven days in offshore oil installation workers
    Gibbs, M
    Hampton, S
    Morgan, L
    Arendt, J
    [J]. NEUROSCIENCE LETTERS, 2002, 325 (02) : 91 - 94
  • [36] Self-report of circadian type reflects the phase of the melatonin rhythm
    Gibertini, M
    Graham, C
    Cook, MR
    [J]. BIOLOGICAL PSYCHOLOGY, 1999, 50 (01) : 19 - 33
  • [37] Effects of light exposure and sleep displacement on dim light melatonin onset
    Gordijn, MCM
    Beersma, DGM
    Korte, HJ
    Van den Hoofdakker, RH
    [J]. JOURNAL OF SLEEP RESEARCH, 1999, 8 (03) : 163 - 174
  • [38] Experiments on the effects of a continuous 16.7 Hz magnetic field on melatonin secretion, core body temperature, and heart rates in humans
    Griefahn, B
    Künemund, C
    Blaszkewicz, M
    Golka, K
    Mehnert, P
    Degen, G
    [J]. BIOELECTROMAGNETICS, 2001, 22 (08) : 581 - 588
  • [39] The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects
    Hack, LM
    Lockley, SW
    Arendt, J
    Skene, DJ
    [J]. JOURNAL OF BIOLOGICAL RHYTHMS, 2003, 18 (05) : 420 - 429
  • [40] Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin
    Härtter, S
    Wang, XM
    Weigmann, H
    Friedberg, T
    Arand, M
    Oesch, F
    Hiemke, C
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (02) : 167 - 174